Investieren Sie in den chancenreichen US-Immobilienmarkt. Mit dem aktuellen Fonds der US Treuhand. Jetzt informieren!-w-
19.10.2021 23:45

Salesforce.com (CRM) Gains But Lags Market: What You Should Know

Folgen
Werbung
Salesforce.com (CRM) closed the most recent trading day at $292.34, moving +0.22% from the previous trading session. This change lagged the S&P 500's 0.74% gain on the day.Heading into today, shares of the customer-management software developer had gained 12.97% over the past month, outpacing the Computer and Technology sector's loss of 0.81% and the S&P 500's gain of 1.34% in that time.CRM will be looking to display strength as it nears its next earnings release. The company is expected to report EPS of $0.92, down 47.13% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $6.79 billion, up 25.27% from the prior-year quarter.For the full year, our Zacks Consensus Estimates are projecting earnings of $4.40 per share and revenue of $26.3 billion, which would represent changes of -10.57% and +23.73%, respectively, from the prior year.Investors might also notice recent changes to analyst estimates for CRM. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 2.82% higher. CRM currently has a Zacks Rank of #1 (Strong Buy).Valuation is also important, so investors should note that CRM has a Forward P/E ratio of 66.35 right now. Its industry sports an average Forward P/E of 35.44, so we one might conclude that CRM is trading at a premium comparatively.Meanwhile, CRM's PEG ratio is currently 3.96. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. Computer - Software stocks are, on average, holding a PEG ratio of 3.02 based on yesterday's closing prices.The Computer - Software industry is part of the Computer and Technology sector. This group has a Zacks Industry Rank of 151, putting it in the bottom 41% of all 250+ industries.The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.To follow CRM in the coming trading sessions, be sure to utilize Zacks.com.Zacks' Top Picks to Cash in on Artificial Intelligence In 2021, this world-changing technology is projected to generate $327.5 billion in revenue. Now Shark Tank star and billionaire investor Mark Cuban says AI will create "the world's first trillionaires." Zacks' urgent special report reveals 3 AI picks investors need to know about today.See 3 Artificial Intelligence Stocks With Extreme Upside Potential>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report salesforce.com, inc. (CRM): Free Stock Analysis Report To read this article on Zacks.com click here.
Weiter zum vollständigen Artikel bei "Zacks"
Quelle: Zacks

Nachrichten zu Salesforce

  • Relevant
    1
  • Alle
    2
  • vom Unternehmen
    1
  • Peer Group
  • ?

Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:

Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen

Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen

vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden

Peer Group: Nachrichten von Unternehmen, die zur Peer Group gehören

Analysen zu Salesforce

  • Alle
  • Buy
  • Hold
  • Sell
  • ?
06.12.2021Salesforce OutperformCredit Suisse Group
01.12.2021Salesforce OverweightJP Morgan Chase & Co.
01.12.2021Salesforce Conviction Buy ListGoldman Sachs Group Inc.
01.12.2021Salesforce BuyJefferies & Company Inc.
29.11.2021Salesforce Conviction Buy ListGoldman Sachs Group Inc.
06.12.2021Salesforce OutperformCredit Suisse Group
01.12.2021Salesforce OverweightJP Morgan Chase & Co.
01.12.2021Salesforce Conviction Buy ListGoldman Sachs Group Inc.
01.12.2021Salesforce BuyJefferies & Company Inc.
29.11.2021Salesforce Conviction Buy ListGoldman Sachs Group Inc.
14.09.2021Salesforce HaltenNorddeutsche Landesbank (Nord/LB)
26.02.2021Salesforce market-performBernstein Research
02.12.2020Salesforce market-performBernstein Research
01.12.2020Salesforce market-performBernstein Research
26.11.2020Salesforce market-performBernstein Research
19.06.2020Slack SellGoldman Sachs Group Inc.
19.05.2016Salesforce UnderperformBernstein Research
19.11.2015Salesforce UnderperformBernstein Research
19.11.2015Salesforce verkaufenJefferies & Company Inc.
22.11.2012Salesforcecom underperformSanford C. Bernstein and Co., Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Salesforce nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"

Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"

Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen
Werbung
Werbung
Werbung
Werbung
Börse Stuttgart Anlegerclub
Werbung

Heute im Fokus

US-Börsen letztlich fester -- DAX schließt in Rot -- BioNTech-Impfstoff bei 3 Dosen effektiv gegen Omikron -- HelloFresh stellt für 2022 weiteres Wachstum in Aussicht -- Apple, HORNBACH, TUI im Fokus

Deutsche Börse verlängert Vertrag von CFO Pottmeyer. Rheinmetall will Pumpen-JV in China und Japan ganz übernehmen. Merck KGaA stockt Venture-Capital-Fonds um Millionenbetrag auf. Volkswagen schmiedet Bund für Batteriezellen - 2022 Stabilisierung der Werksauslastung erwartet. Moody's erhöht Daimler-Ausblick auf positiv. Baader-Studie vertreibt Ceconomy-Anleger.

Umfrage

Wie hat sich Ihr Wertpapierdepot seit Jahresbeginn entwickelt?

finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln